AMPLI – PPHI Accelerating Measurable Progress and Leveraging Investments for Postpartum Hemorrhage Impact Did you know? Postpartum hemorrhage (PPH) is the leading cause of maternal death worldwide. AMPLI-PPHI will catalyze early adoption and scale-up of new and recently recommended drugs to prevent or treat PPH in high-burden countries as part of an integrated package of
August 16, 2022 Baltimore, MD—Jhpiego, a global leader in maternal health care, has been chosen to lead a new $18.5 million project funded by Unitaid that will inform how countries can introduce and accelerate use of key drugs to prevent and treat life-threatening bleeding after birth. The Accelerating Measurable Progress and Leveraging Investments for Postpartum
Building Resilient Health Systems for a Safer World Strong public health systems not only enable families and communities to thrive, but also help to ensure stable economies and countries. Jhpiego works with governments and other stakeholders to strengthen health systems and the policies and legislation that support them, so that countries can prevent, detect and